Navigation Links
Eclipse Aesthetics, LLC Files Suit Against RegenLab USA, LLC
Date:7/23/2014

DALLAS, July 23, 2014 /PRNewswire/ -- On Tuesday, July 1, 2014, Eclipse Aesthetics, LLC ("Plaintiff") filed suit in the 116th Judicial District Court in Dallas, Texas, against RegenLab USA, LLC ("Defendant") for Tortious Interference with Current and Prospective Business Relationships through false and misleading actions, fraud, fraud-in-the-inducement, business interference, tortious interference; and, Business Disparagement through libel, disparagement, defamation, misrepresentation, and violating the false/deceptive advertising laws (among other laws) that are valid in every state in the United States.

Eclipse Aesthetics is a developer and supplier of aesthetic-based products for cosmetic procedures including Platelet Rich Plasma (Eclipse PRP™). RegenLab USA designs, develops, manufactures, and commercializes Platelet Rich Plasma (PRP) for professional markets.

As a result of RegenLab USA knowingly sending a false, fraudulent, and deceptive Promotional E-mail that was intentionally designed to disparage Eclipse and Eclipse PRP™ while damaging its standing within the medical care community, Eclipse has filed suit against RegenLab USA.

CONTACT: Info@eclipsemed.com, 800-759-6876

Logo - http://photos.prnewswire.com/prnh/20131203/LA27104LOGO


'/>"/>
SOURCE Eclipse Aesthetics, LLC
Copyright©2014 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse
2. MiMedx Files Its Initial Investigational New Drug Application
3. Valeant Pharmaceuticals Files Investor Presentation
4. ViaCyte Files Investigational New Drug Application and Device Master File with FDA for Novel Cell Replacement Therapy Product Candidate Designed to Treat Patients with Type 1 Diabetes
5. BioSpain 2014 Expands its Investment Forum Through Wider Range of Investor Profiles and more Participating Companies
6. Otonomy Files Registration Statement for Proposed Initial Public Offering
7. MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics
8. EntreMed Files New Drug Global Clinical Trial Application For ENMD-2076 With China CFDA
9. Flexion Therapeutics Files Registration Statement for Proposed Initial Public Offering
10. Ormco Corporation Files Appeal to the Federal Court Against Ortho Classic H4 Bracket Patent Infringement
11. Molecular Profiles Joins Leading Consortium To Drive Paediatric Formulation Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... -- ITL Limited, ( ASX: ITD ), an innovative diversified healthcare ... ended 31 December 2016 compared with the previous corresponding period. A ... here . Highlights ... Earnings per share of 2.2 cents (Dec 2015: 1.2 ... $15.7m; up 11%) Profit before tax of $2.12m ...
(Date:2/23/2017)... Research and Markets has announced the addition of the "Oesophageal ... their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis and Strategies - ... Cancer market. The research answers the following questions: ... Oesophageal Cancer and their clinical attributes? How are they positioned in ...
(Date:2/23/2017)... VALLEY COTTAGE, New York , February 23, 2017 ... to health implications arising from increasing caseload for varicose ... cases recorded across the globe are prompting the adoption ... A latest study on global endovenous laser therapy ... growing attention towards aftereffects of lifestyle choices and consequences ...
Breaking Medicine Technology:
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... Yisrayl Hawkins, ... focuses on Bible Prophecy concerning this present generation. Yisrayl makes an astounding statement ... current generation. He explains that the Bible details the current times so plainly ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to Head Over Heels’ ... February 12th. Ms. Esparza qualified into this prestigious status after winning the ... Las Vegas, Nevada. Frida is one of approximately 25 gymnasts in the nation ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... return to the La Gorce Country Club in Miami Beach to host its ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a ... content marketing, social media management, corporate communications, SEO and cause marketing, is opening ... in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... and uncertainty in clinical trials, today announced that Premier Research, a leading clinical ... solution. , Clinical trials are becoming increasingly complex, due in part to an ...
Breaking Medicine News(10 mins):